XML 28 R11.htm IDEA: XBRL DOCUMENT

Fair Value Option

9 Months Ended

Sep. 30, 2023

Fair value option

The fair value option provides an option to elect fair value for selected financial assets, financial liabilities, unrecognized firm commitments, and written loan commitments.

The Firm has elected to measure certain instruments at fair value for several reasons including to mitigate income statement volatility caused by the differences between the measurement basis of elected instruments (e.g., certain instruments that otherwise would be accounted for on an accrual basis) and the associated risk management arrangements that are accounted for on a fair value basis, as well as to better reflect those instruments that are managed on a fair value basis.

The Firm’s election of fair value includes the following instruments:

•Loans purchased or originated as part of securitization warehousing activity, subject to bifurcation accounting, or managed on a fair value basis, including lending-related commitments

•Certain securities financing agreements

•Owned beneficial interests in securitized financial assets that contain embedded credit derivatives, which would otherwise be required to be separately accounted for as a derivative instrument

•Structured notes and other hybrid instruments, which are predominantly financial instruments that contain embedded derivatives, that are issued or transacted as part of client-driven activities

•Certain long-term beneficial interests issued by CIB’s consolidated securitization trusts where the underlying assets are carried at fair value

Changes in fair value under the fair value option election

The following table presents the changes in fair value included in the Consolidated statements of income for the three and nine months ended September 30, 2023 and 2022, for items for which the fair value option was elected. The profit and loss information presented below only includes the financial instruments that were elected to be measured at fair value; related risk management instruments, which are required to be measured at fair value, are not included in the table.


	Three months ended September 30,
	2023							2022
(in millions)	Principal transactions		All other income			Total changes in fair value recorded (e)		Principal transactions		All other income			Total changes in fair value recorded (e)
Federal funds sold and securities purchased under resale agreements	$	146	$	—		$	146	$	(185)	$	—		$	(185)
Securities borrowed	29		—			29		(209)		—			(209)
Trading assets:
Debt and equity instruments, excluding loans	200		—			200		(1,782)		—			(1,782)
Loans reported as trading assets:
Changes in instrument-specific credit risk	17		—			17		34		—			34
Other changes in fair value	4		—			4		(36)		—			(36)
Loans:
Changes in instrument-specific credit risk	31		4		(c)	35		(133)		3		(c)	(130)
Other changes in fair value	(74)		(78)		(c)	(152)		(340)		(107)		(c)	(447)
Other assets	32		(1)		(d)	31		12		(7)		(d)	5
Deposits(a)	(454)		—			(454)		364		—			364
Federal funds purchased and securities loaned or sold under repurchase agreements	(17)		—			(17)		104		—			104
Short-term borrowings(a)	(130)		—			(130)		85		—			85
Trading liabilities	4		—			4		9		—			9
Beneficial interests issued by consolidated VIEs	—		—			—		—		—			—
Other liabilities	(2)		—			(2)		(2)		—			(2)
Long-term debt(a)(b)	2,606		(14)		(c)(d)	2,592		1,828		125		(c)(d)	1,953


	Nine months ended September 30,
	2023							2022
(in millions)	Principal transactions		All other income			Total changes in fair value recorded (e)		Principal transactions		All other income			Total changes in fair value recorded (e)
Federal funds sold and securities purchased under resale agreements	$	366	$	—		$	366	$	(560)	$	—		$	(560)
Securities borrowed	57		—			57		(508)		—			(508)
Trading assets:
Debt and equity instruments, excluding loans	2,955		—			2,955		(2,693)		—			(2,693)
Loans reported as trading assets:
Changes in instrument-specific credit risk	248		—			248		(109)		—			(109)
Other changes in fair value	9		2		(c)	11		(58)		—			(58)
Loans:
Changes in instrument-specific credit risk	102		—			102		(210)		26		(c)	(184)
Other changes in fair value	45		26		(c)	71		(1,560)		(881)		(c)	(2,441)
Other assets	46		(2)		(d)	44		21		(6)		(d)	15
Deposits(a)	(1,322)		—			(1,322)		1,148		—			1,148
Federal funds purchased and securities loaned or sold under repurchase agreements	(86)		—			(86)		310		—			310
Short-term borrowings(a)	(399)		—			(399)		858		—			858
Trading liabilities	(26)		—			(26)		(3)		—			(3)
Beneficial interests issued by consolidated VIEs	—		—			—		(1)		—			(1)
Other liabilities	(3)		—			(3)		(6)		—			(6)
Long-term debt(a)(b)	(855)		(42)		(c)(d)	(897)		11,193		158		(c)(d)	11,351

(a)Unrealized gains/(losses) due to instrument-specific credit risk (DVA) for liabilities for which the fair value option has been elected are recorded in OCI, while realized gains/(losses) are recorded in principal transactions revenue. Realized gains/(losses) due to instrument-specific credit risk recorded in principal transactions revenue were not material both for the three and nine months ended September 30, 2023 and 2022.

(b)Long-term debt measured at fair value predominantly relates to structured notes. Although the risk associated with the structured notes is actively managed, the gains/(losses) reported in this table do not include the income statement impact of the risk management instruments used to manage such risk.

(c)Reported in mortgage fees and related income.

(d)Reported in other income.

(e)Changes in fair value exclude contractual interest, which is included in interest income and interest expense for all instruments other than certain hybrid financial instruments in CIB. Refer to Note 7 for further information regarding interest income and interest expense.

Difference between aggregate fair value and aggregate remaining contractual principal balance outstanding

The following table reflects the difference between the aggregate fair value and the aggregate remaining contractual principal balance outstanding as of September 30, 2023 and December 31, 2022, for loans, long-term debt and long-term beneficial interests for which the fair value option has been elected.


	September 30, 2023							December 31, 2022
(in millions)	Contractual principal outstanding			Fair value		Fair value over/(under) contractual principal outstanding		Contractual principal outstanding			Fair value		Fair value over/(under) contractual principal outstanding
Loans
Nonaccrual loans
Loans reported as trading assets	$	3,080		$	572	$	(2,508)	$	2,517		$	368	$	(2,149)
Loans	875			750		(125)		967			829		(138)
Subtotal	3,955			1,322		(2,633)		3,484			1,197		(2,287)
90 or more days past due and government guaranteed
Loans(a)	71			65		(6)		124			115		(9)
All other performing loans(b)
Loans reported as trading assets	9,009			7,574		(1,435)		7,823			6,135		(1,688)
Loans	39,212			37,993		(1,219)		42,588			41,135		(1,453)
Subtotal	48,221			45,567		(2,654)		50,411			47,270		(3,141)
Total loans	$	52,247		$	46,954	$	(5,293)	$	54,019		$	48,582	$	(5,437)
Long-term debt
Principal-protected debt	$	45,221	(d)	$	34,331	$	(10,890)	$	41,341	(d)	$	31,105	$	(10,236)
Nonprincipal-protected debt(c)	NA			44,026		NA		NA			41,176		NA
Total long-term debt	NA			$	78,357	NA		NA			$	72,281	NA
Long-term beneficial interests
Nonprincipal-protected debt(c)	NA			$	66	NA		NA			$	5	NA
Total long-term beneficial interests	NA			$	66	NA		NA			$	5	NA

(a)These balances are excluded from nonaccrual loans as the loans are insured and/or guaranteed by U.S. government agencies.

(b)There were no performing loans that were ninety days or more past due as of September 30, 2023 and December 31, 2022.

(c)Remaining contractual principal is not applicable to nonprincipal-protected structured notes and long-term beneficial interests. Unlike principal-protected structured notes and long-term beneficial interests, for which the Firm is obligated to return a stated amount of principal at maturity, nonprincipal-protected structured notes and long-term beneficial interests do not obligate the Firm to return a stated amount of principal at maturity, but for structured notes to return an amount based on the performance of an underlying variable or derivative feature embedded in the note. However, investors are exposed to the credit risk of the Firm as issuer for both nonprincipal-protected and principal-protected notes.

(d)Where the Firm issues principal-protected zero-coupon or discount notes, the balance reflects the contractual principal payment at maturity or, if applicable, the contractual principal payment at the Firm’s next call date.

At September 30, 2023 and December 31, 2022, the contractual amount of lending-related commitments for which the fair value option was elected was $13.0 billion and $7.6 billion, respectively, with a corresponding fair value of $247 million and $24 million, respectively. Refer to Note 28 of JPMorgan Chase’s 2022 Form 10-K, and Note 24 of this Form 10-Q for further information regarding off-balance sheet lending-related financial instruments.

Structured note products by balance sheet classification and risk component

The following table presents the fair value of structured notes, by balance sheet classification and the primary risk type.


	September 30, 2023									December 31, 2022
(in millions)	Long-term debt		Short-term borrowings		Deposits			Total		Long-term debt		Short-term borrowings		Deposits			Total
Risk exposure
Interest rate	$	34,449	$	271	$	60,595		$	95,315	$	31,973	$	260	$	24,655		$	56,888
Credit	4,746		365		—			5,111		4,105		170		—			4,275
Foreign exchange	2,373		953		112			3,438		2,674		788		50			3,512
Equity	34,007		5,850		2,986			42,843		30,864		4,272		3,545			38,681
Commodity	1,989		21		1		(a)	2,011		1,655		16		2		(a)	1,673
Total structured notes	$	77,564	$	7,460	$	63,694		$	148,718	$	71,271	$	5,506	$	28,252		$	105,029

(a)Excludes deposits linked to precious metals for which the fair value option has not been elected of $587 million and $602 million for the periods ended September 30, 2023 and December 31, 2022, respectively.

- Definition

The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide. Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.

+ References + Details